Machete identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works

Robust enumeration of cell subsets from tissue expression profiles

Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 12,116 · see citing works

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works

UMAP: Uniform Manifold Approximation and Projection

McInnes, L., Healy, J., Saul, N., & Großberger, L. (2018) · Journal of Open Source Software · doi:10.21105/joss.00861 · Cited by 9,826 · see citing works

SCANPY: large-scale single-cell gene expression data analysis

Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881 · see citing works

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814 · see citing works

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works

The landscape of somatic copy-number alteration across human cancers

Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017 · see citing works

The cancer genome

Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,459 · see citing works

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,414 · see citing works

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159 · see citing works

Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden

Hellmann, M. D., Ciuleanu, T.-E., Pluzanski, A., Lee, J. S., Otterson, G. A., Audigier-Valette, C., Minenza, E., Linardou, H., Burgers, S., Salman, P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801946 · Cited by 3,063 · see citing works

Tumour evolution inferred by single-cell sequencing

Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598 · see citing works

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · see citing works

Functional Role of Type I and Type II Interferons in Antiviral Defense

Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · see citing works

Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis

Levine, J. H., Simonds, E. F., Bendall, S. C., Davis, K. L., Amir, E.-A. D., Tadmor, M. D., Litvin, O., Fienberg, H. G., Jager, A., Zunder, E. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.047 · Cited by 2,303 · see citing works

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194 · see citing works

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., Chandramohan, R., Liu, Z. Y., Won, H. H., Scott, S. N., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.12.006 · Cited by 2,119 · see citing works

The reactome pathway knowledgebase

Jassal, B., Matthews, L. R., Viteri, G., Gong, C., Lorente, P., Fabregat, A., Sidiropoulos, K., Cook, J., Gillespie, M. E., Haw, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1031 · Cited by 2,111 · see citing works

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment

Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976 · see citing works

Pan-cancer patterns of somatic copy number alteration

Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C., Wala, J. A., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,843 · see citing works

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works

Type I interferons in anticancer immunity

Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305 · see citing works

Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy

Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300 · see citing works

The Reactome pathway Knowledgebase

Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 1,201 · see citing works

Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics

Stoeckius, M., Zheng, S., Houck-Loomis, B., Hao, S., Yeung, B. Z., Mauck, W. M., Smibert, P., & Satija, R. (2018) · Genome Biology · doi:10.1186/s13059-018-1603-1 · Cited by 1,046 · see citing works

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Taylor, A. M., Shih, J., Ha, G., Gao, G. F., Zhang, X., Berger, A. C., Schumacher, S. E., Wang, C., Hu, H., Liu, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.007 · Cited by 1,027 · see citing works

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

Braun, D. A., Hou, Y., Bakouny, Z., Ficial, M., Sant’ Angelo, M., Forman, J., Ross-Macdonald, P., Berger, A. C., Jegede, O. A., Elagina, L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0839-y · Cited by 992 · see citing works

The INK4a/ARF network in tumour suppression

Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 984 · see citing works

Differential abundance testing on single-cell data using k-nearest neighbor graphs

Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D., & Marioni, J. C. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01033-z · Cited by 938 · see citing works

Antitumour actions of interferons: implications for cancer therapy

Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.14 · Cited by 897 · see citing works

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872 · see citing works

Patterns of somatic structural variation in human cancer genomes

Li, Y., Roberts, N. D., Wala, J. A., Shapira, O., Schumacher, S. E., Kumar, K., Khurana, E., Waszak, S., Korbel, J. O., Haber, J. E., et al. (2020) · Nature · doi:10.1038/s41586-019-1913-9 · Cited by 867 · see citing works

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome

Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815 · see citing works

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

Li, J., Byrne, K. T., Yan, F., Yamazoe, T., Chen, Z., Baslan, T., Richman, L. P., Lin, J., Sun, Y. H., Rech, A. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.006 · Cited by 738 · see citing works

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G., & Bar-Sagi, D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.024 · Cited by 721 · see citing works

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Chan-Seng-Yue, M., Kim, J. C., Wilson, G. W., Ng, K., Figueroa, E. F., O’Kane, G. M., Connor, A. A., Denroche, R. E., Grant, R. C., McLeod, J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0566-9 · Cited by 669 · see citing works

Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial

Aung, K. L., Fischer, S. E., Denroche, R. E., Jang, G.-H., Dodd, A., Creighton, S., Southwood, B., Liang, S.-B., Chadwick, D., Zhang, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2994 · Cited by 618 · see citing works

Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

Bardeesy, N. M., Aguirre, A. J., Chu, G. C., Cheng, K., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C. W., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 575 · see citing works

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

Ahuja, D., Sáenz-Robles, M. T., & Pipas, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209046 · Cited by 559 · see citing works

Expression of tumour-specific antigens underlies cancer immunoediting

DuPage, M. J. P., Mazumdar, C., Schmidt, L., Cheung, A. F., & Jacks, T. (2012) · Nature · doi:10.1038/nature10803 · Cited by 529 · see citing works

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N. E., Samarajiwa, S. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2830 · Cited by 487 · see citing works

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Ruscetti, M., Morris, J. P., Mezzadra, R., Russell, J., Leibold, J., Romesser, P. B., Simon, J., Kulick, A., Ho, Y.-J., Fennell, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.008 · Cited by 424 · see citing works

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Mueller, S., Engleitner, T., Maresch, R., Zukowska, M., Lange, S., Kaltenbacher, T., Konukiewitz, B., Öllinger, R., Zwiebel, M., Strong, A., et al. (2018) · Nature · doi:10.1038/nature25459 · Cited by 420 · see citing works

Type I interferon response and innate immune sensing of cancer

Fuertes, M. B., Woo, S.-R., Burnett, B., Fu, Y.-X., & Gajewski, T. F. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.004 · Cited by 375 · see citing works

Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

Duong, E., Fessenden, T. B., Lutz, E., Dinter, T., Yim, L., Blatt, S., Bhutkar, A., Wittrup, K. D., & Spranger, S. (2022) · Immunity · doi:10.1016/j.immuni.2021.10.020 · Cited by 372 · see citing works

IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia

Pylayeva‐Gupta, Y., Das, S., Handler, J. S., Hajdu, C. H., Coffre, M., Koralov, S. B., & Bar‐Sagi, D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0843 · Cited by 357 · see citing works

Recurrent chromosome aberrations in cancer

Mitelman, F. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00006-5 · Cited by 346 · see citing works

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

Fan, X., Quezada, S. A., Sepulveda, M. A., Sharma, P., & Allison, J. P. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130590 · Cited by 300 · see citing works

Deletions linked to TP53 loss drive cancer through p53-independent mechanisms

Liu, Y., Chen, C., Xu, Z., Scuoppo, C., Rillahan, C. D., Gao, J., Spitzer, B. G., Bosbach, B., Kastenhuber, E. R., Baslan, T., et al. (2016) · Nature · doi:10.1038/nature17157 · Cited by 272 · see citing works

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Gundry, M. C., Brunetti, L., Lin, A., Mayle, A. E., Kitano, A., Wagner, D., Hsu, J. I., Hoegenauer, K. A., Rooney, C. M., Goodell, M. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.092 · Cited by 265 · see citing works

Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection

Fung, K. Y., Mangan, N. E., Cumming, H. E., Horvat, J. C., Mayall, J., Stifter, S. A., de Weerd, N. A., Roisman, L. C., Rossjohn, J., Robertson, S. A., et al. (2013) · Science · doi:10.1126/science.1233321 · Cited by 264 · see citing works

Cytosolic DNA Sensing in Organismal Tumor Control

Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250 · see citing works

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Montesion, M., Murugesan, K., Jin, D. X., Sharaf, R., Sánchez, N., Guria, A., Minker, M., Li, G., Fisher, V. A., Sokol, E. S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0672 · Cited by 244 · see citing works

GuideScan software for improved single and paired CRISPR guide RNA design

Perez, A. R., Pritykin, Y., Vidigal, J. A., Chhangawala, S., Zamparo, L., Leslie, C. S., & Ventura, A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3804 · Cited by 242 · see citing works

Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer

Balli, D., Rech, A. J., Stanger, B. Z., & Vonderheide, R. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2128 · Cited by 235 · see citing works

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

Han, G., Yang, G., Hao, D., Lü, Y., Thein, K. Z., Simpson, B. S. S., Chen, J., Sun, R., Alhalabi, O., Wang, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25894-9 · Cited by 233 · see citing works

Review: a meta‐analysis of GWAS and age‐associated diseases

Jeck, W. R., Siebold, A. P., & Sharpless, N. E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00871.x · Cited by 204 · see citing works

Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism

Cai, Y., Crowther, J., Pastor, T., Asbagh, L. A., Baietti, M. F., Troyer, M. D., Vázquez, I., Talebi, A., Renzi, F., Dehairs, J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.003 · Cited by 191 · see citing works

Aneuploidy as a promoter and suppressor of malignant growth

Vasudevan, A., Schukken, K. M., Sausville, E. L., Girish, V., Adebambo, O. A., & Sheltzer, J. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00321-1 · Cited by 176 · see citing works

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions

Xue, W., Kitzing, T. M., Roessler, S. K., Zuber, J. A., Krasnitz, A., Schultz, N. D., Revill, K., Weissmueller, S., Rappaport, A., Simon, J. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206062109 · Cited by 171 · see citing works

Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences

Kumar, S., Warrell, J., Li, S., McGillivray, P. D., Meyerson, W. U., Salichos, L., Harmanci, A. O., Martinez‐Fundichely, A., Chan, C. W. Y., Nielsen, M. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.032 · Cited by 166 · see citing works

Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays

Harada, T., Chelala, C., Bhakta, V, Chaplin, T., Caulee, K., Baril, P., Young, B. D., & Lemoine, N. R. (2008) · Oncogene · doi:10.1038/sj.onc.1210832 · Cited by 159 · see citing works

Systematic identification of mutations and copy number alterations associated with cancer patient prognosis

Smith, J. C., & Sheltzer, J. M. (2018) · eLife · doi:10.7554/elife.39217 · Cited by 138 · see citing works

Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells

Lee, K. E., & Bar‐Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 133 · see citing works

Collateral lethality: a new therapeutic strategy in oncology

Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132 · see citing works

Optimizing sparse sequencing of single cells for highly multiplex copy number profilingPreprint

Baslan, T., Kendall, J., Ward, B., Cox, H., Leotta, A., Rodgers, L., Riggs, M. G., D'Italia, S., Sun, G., Mao, Y., et al. (2015) · Genome Research · doi:10.1101/gr.188060.114 · Cited by 122 · see citing works

Precancerous neoplastic cells can move through the pancreatic ductal system

Makohon-Moore, A. P., Matsukuma, K., Zhang, M., Reiter, J. G., Gerold, J. M., Jiao, Y., Sikkema, L., Attiyeh, M. A., Yachida, S., Sandone, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0481-8 · Cited by 120 · see citing works

Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice

Dow, L. E., Nasr, Z., Saborowski, M., Ebbesen, S. H., Manchado, E., Tasdemir, N., Lee, T., Pelletier, J., & Lowe, S. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095236 · Cited by 112 · see citing works

Chromosome engineering in zygotes with CRISPR / C as9

Boroviak, K., Doe, B., Banerjee, R., Yang, F., & Bradley, A. (2016) · genesis · doi:10.1002/dvg.22915 · Cited by 91 · see citing works

A modular and flexible ESC-based mouse model of pancreatic cancerPreprint

Saborowski, M., Saborowski, A., Morris, J. P., Bosbach, B., Dow, L. E., Pelletier, J., Klimstra, D., & Lowe, S. (2014) · Genes & Development · doi:10.1101/gad.232082.113 · Cited by 75 · see citing works

Molecular processes of chromosome 9p21 deletions in human cancers

Sasaki, S., Kitagawa, Y., Sekido, Y., Minna, J. D., Kuwano, H., Yokota, J., & Kohno, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206589 · Cited by 69 · see citing works

Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance

Ye, Z., Dong, H., Li, Y., Ma, T., Huang, H., Leong, H. S., Eckel‐Passow, J. E., Kocher, J., Liang, H., & Wang, L. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3008 · Cited by 60 · see citing works

Highly efficient targeted chromosome deletions using CRISPR/Cas9

He, Z., Proudfoot, C., Mileham, A. J., McLaren, D. G., Whitelaw, B., & Lillico, S. G. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25490 · Cited by 59 · see citing works

Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase ( MTAP ) Die Prematurely of T-Cell Lymphoma

Kadariya, Y., Yin, B., Tang, B., Shinton, S. A., Quinlivan, E. P., Xiang, H., Klein–Szanto, A. J., Al‐Saleem, T., Bassing, C. H., Hardy, R. R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0145 · Cited by 50 · see citing works

All is not lost: learning from 9p21 loss in cancer

Spiliopoulou, P., Yang, S. Y. C., Bruce, J. P., Wang, B. X., Berman, H. K., Pugh, T. J., & Siu, L. L. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.03.003 · Cited by 50 · see citing works

Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer

Ortiz, A., & Fuchs, S. Y. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.010 · Cited by 35 · see citing works

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma

Litvin, O., Schwartz, S., Wan, Z., Schild, T., Rocco, M., Oh, N. L., Chen, B.-J., Goddard, N. L., Pratilas, C. A., & Pe’er, D. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.030 · Cited by 29 · see citing works

Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses

Hertzog, P. J. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.15 · Cited by 28 · see citing works

Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing

Mishra, A. K., Emamgholi, F., Erlangga, Z., Hartleben, B., Unger, K., Wolff, K., Teichmann, U., Kessel, M., Woller, N., Kühnel, F., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz108 · Cited by 9 · see citing works

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Lü, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Cañadas, I., Tian, Y., Niu, X., Wang, Y. Z., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 376 · see citing works

Chromosomal instability as a driver of cancer progression

Chen, X., Agustinus, A. S., Li, J., Bona, M. D., & Bakhoum, S. F. W. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00761-7 · Cited by 134 · see citing works

Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain

Gan, S., Macalinao, D. G., Shahoei, S. H., Tian, L. H., Jin, X., Basnet, H., Bibby, C., Muller, J., Atri, P., Seffar, E., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.015 · Cited by 94 · see citing works

Escape from T-cell–targeting immunotherapies in acute myeloid leukemia

Vadakekolathu, J. N., & Rutella, S. (2023) · Blood · doi:10.1182/blood.2023019961 · Cited by 73 · see citing works

Interferon-ε is a tumour suppressor and restricts ovarian cancer

Marks, Z. R. C., Campbell, N. K., Mangan, N. E., Vandenberg, C. J., Gearing, L. J., Matthews, A. Y., Gould, J. A., Tate, M. D., Wray‐McCann, G., Ying, L., et al. (2023) · Nature · doi:10.1038/s41586-023-06421-w · Cited by 70 · see citing works

Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities

Konen, J. M., Wu, H., & Gibbons, D. L. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.04.006 · Cited by 72 · see citing works

Nivolumab for Patients With High-Risk Oral Leukoplakia

Hanna, G. J., Villa, A., Nandi, S. P., Shi, R., O’Neill, A., Liu, M., Quinn, C. T., Treister, N. S., Sroussi, H., Vacharotayangul, P., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.4853 · Cited by 66 · see citing works

Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

Spain, L. A., Coulton, A., Lobón, I., Rowan, A., Schnidrig, D., Shepherd, S. T. C., Shum, B., Byrne, F., Goicoechea, M., Piperni, E., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1427 · Cited by 55 · see citing works

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer

Singh, H., Keller, R. B., Kapner, K. S., Dilly, J., Raghavan, S., Yuan, C., Cohen, E. F., Tolstorukov, M. Y., Andrews, E., Brais, L. K., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3930 · Cited by 49 · see citing works

Aneuploidy as a driver of human cancer

Sdeor, E., Okada, H., Saad, R., Ben-Yishay, T., & Ben‐David, U. (2024) · Nature Genetics · doi:10.1038/s41588-024-01916-2 · Cited by 46 · see citing works

Evolutionary fingerprints of epithelial-to-mesenchymal transition

Perelli, L., Zhang, L., Mangiameli, S. M., Giannese, F., Mahadevan, K. K., Peng, F., Citron, F., Khan, H., Le, C. N., Gurreri, E., et al. (2025) · Nature · doi:10.1038/s41586-025-08671-2 · Cited by 48 · see citing works

Metabolic adaptations direct cell fate during tissue regeneration

Perez, A. C., Millman, S. E., Janaki‐Raman, S., Ho, Y.-J., Hinterleitner, C., Barthet, V. J. A., Morris, J. P., Barriga, F. M., Reyes, J. S., Kyaw, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09097-6 · Cited by 47 · see citing works

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

Pouyiourou, M., Kraft, B. N., Wohlfromm, T., Ståhl, M., Kubuschok, B., Löffler, H., Hacker, U. T., Hübner, G., Weiss, L., Bitzer, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42400-5 · Cited by 42 · see citing works

Genomic instability as a driver and suppressor of anti-tumor immunity

Requesens, M., Foijer, F., Nijman, H. W., & de Bruyn, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462496 · Cited by 44 · see citing works

Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas

Wu, J., Castro, L. N. G., Battaglia, S., Farran, C. A. E., D’Antonio, J. P., Miller, T. E., Suvà, M. L., & Bernstein, B. (2024) · Nature Cancer · doi:10.1038/s43018-024-00865-3 · Cited by 41 · see citing works

Defining precancer: a grand challenge for the cancer community

Faupel‐Badger, J. M., Kohaar, I., Bahl, M., Chan, A. T., Campbell, J. D., Li, J., Marzo, A. M. D., Maitra, A., Merrick, D. T., Hawk, E. T., et al. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00744-0 · Cited by 42 · see citing works

Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers

Ngoi, N. Y. L., Tang, T., Gaspar, C. F., Pavlick, D. C., Buchold, G. M., Scholefield, E. L., Parimi, V., Huang, R. S. P., Janovitz, T., Danziger, N. A., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyae011 · Cited by 43 · see citing works

Targeting STING to generate therapeutic anti-tumor immunity

Fahey, C. G., Cordova, A. F., Gedeon, P. C., & Barbie, D. A. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.12.002 · Cited by 35 · see citing works

Targeting chromosomal instability and aneuploidy in cancer

Bhatia, S., Khanna, K. K., & Duijf, P. H. G. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.01.009 · Cited by 28 · see citing works

Copy number alterations: a catastrophic orchestration of the breast cancer genome

Shahrouzi, P., Forouz, F., Mathelier, A., Kristensen, V. N., & Duijf, P. H. G. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.04.017 · Cited by 27 · see citing works

MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors

Chen, S., Hou, J., Jaffery, R., Guerrero, A. M., Fu, R., Shi, L., Zheng, N., Bohat, R., Egan, N. A., Yu, C., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009600 · Cited by 27 · see citing works

Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer

Huth, T., Dreher, E. C., Lemke, S., Fritzsche, S., Sugiyanto, R. N., Castven, D., Ibberson, D., Sticht, C., Eiteneuer, E. M., Jauch, A. S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh1442 · Cited by 26 · see citing works

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer

Soto‐Feliciano, Y. M., Zhu, C., Morris, J. P., Huang, C., Koche, R. P., Ho, Y.-J., Banito, A., Chen, C.-W. D., Shroff, A., Tian, S., et al. (2023) · eLife · doi:10.7554/elife.80854 · Cited by 26 · see citing works

SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO

Borck, P. C., Boyle, I., Janković, K., Bick, N. R., Foster, K. J., Lau, A. C., Parker-Burns, L., Lubicki, D. A., Li, T., Borah, A. A., et al. (2025) · Nature · doi:10.1038/s41586-024-08509-3 · Cited by 23 · see citing works

Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement

Moghaddam, S. J., Savai, R., Salehi‐Rad, R., Sengupta, S., Kammer, M. N., Massion, P. P., Beane, J., Ostrin, E. J., Priolo, C., Tennis, M. A., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202406-1168st · Cited by 26 · see citing works

Aneuploidy in human cancer: new tools and perspectives

Lakhani, A. A., Thompson, S. L., & Sheltzer, J. M. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.09.002 · Cited by 24 · see citing works

Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors

Fernández-García, F., Fernández-Rodríguez, A., Torre, C. F., Piñeiro-Yáñez, E., Wang, H., Lechuga, C. G., Callejas, S., Álvarez, R., López-García, A., Esteban-Burgos, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402913121 · Cited by 21 · see citing works

Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer

Ganguli, P., Basanta, C. D. L. A. C., Acha‐Sagredo, A., Mišetić, H., Armero, M., Mendez, A., Zahra, A., Devonshire, G., Kelly, G. P., Freeman, A., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00876-0 · Cited by 26 · see citing works

Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma

Pham, D.-X., & Hsu, T. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-024-01111-9 · Cited by 20 · see citing works

Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival

Bailey, P. J., Zhou, X., An, J., Peccerella, T., Hu, K., Springfeld, C., Büchler, M. W., & Neoptolemos, J. P. (2023) · Function · doi:10.1093/function/zqad011 · Cited by 17 · see citing works

Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction

Zhao, X., Liu, B., William, W. N., Tsanov, K. M., Ho, Y.-J., Barriga, F. M., Lim, R. J., Trifas, M., Khandekar, A., Du, Y., et al. (2024) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2024.12.020 · Cited by 17 · see citing works

Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise

Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 18 · see citing works

Early immune evasion in colorectal cancer: interplay between stem cells and the tumor microenvironment

Goto, N., Agudo, J., & Yilmaz, Ö. H. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.016 · Cited by 17 · see citing works

Emerging Prognostic and Predictive Factors in Pancreatic Cancer

Karamitopoulou, E. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100328 · Cited by 15 · see citing works

Immune evasion: An imperative and consequence of MYC deregulation

Krenz, B., Lee, J., Kannan, T., & Eilers, M. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13695 · Cited by 15 · see citing works

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

Serafini, M. S., Cavalieri, S., Licitra, L. F., Pistore, F., Lenoci, D., Canevari, S., Airoldi, M., Rocca, M. C., Strojan, P., Kuhar, C. G., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007823 · Cited by 14 · see citing works

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

Carey-Smith, S. L., Kotecha, R. S., Cheung, L. C., & Malinge, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136815 · Cited by 17 · see citing works

Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study

Zhang, J., Li, X., Lu, Y., Wang, G., & Ma, Y. (2023) · Cancers · doi:10.3390/cancers15123146 · Cited by 14 · see citing works

Deciphering permissivity of human tumor ecosystems to oncolytic viruses

Schoeps, B., Lauer, U. M., & Elbers, K. (2025) · Oncogene · doi:10.1038/s41388-025-03357-5 · Cited by 13 · see citing works

Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches

Gu, M., Liu, Y., Xin, P., Guo, W., Zhao, Z., Xu, Y., Ma, R., Jiao, T., & Zheng, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216738 · Cited by 13 · see citing works

Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal

Fernández-Sanromán, Á., Fendler, A., Tan, B. J. Y., Cattin, A.-L., Spencer, C. E., Thompson, R. H., Au, L., Lobón, I., Pallikonda, H. A., Martin, A., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0499 · Cited by 13 · see citing works

Genome instability and crosstalk with the immune response

Chabanon, R. M., Danlos, F. X., Ouali, K., & Postel-Vinay, S. C. (2025) · Genome Medicine · doi:10.1186/s13073-025-01509-6 · Cited by 13 · see citing works

ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma

Yu, V. Z., So, S. S., Lung, B. C.-C., Hou, G. Z., Wong, C. W.-Y., Chow, L. K.-Y., Chung, M. K. Y., Wong, Y., Wong, C. L.-Y., Chan, D. K., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216999 · Cited by 12 · see citing works

Selection forces underlying aneuploidy patterns in cancer

Klockner, T. C., & Campbell, C. S. (2024) · Molecular & Cellular Oncology · doi:10.1080/23723556.2024.2369388 · Cited by 12 · see citing works

MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists

Hsu, J.-M., Liu, C., Xia, W., Chen, C., Cheng, W., Hou, J., & Hung, M. (2025) · Science · doi:10.1126/science.adl4089 · Cited by 11 · see citing works

Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas

Jiang, Y., Wu, Y., Zhang, L., Wang, Y., Xu, G., Deng, Y., Han, L., Li, E., Ma, Q., Xu, M., et al. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad030 · Cited by 11 · see citing works

Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment

Chatelain, C., Berland, L., G�rard, M., Jouand, N., Fresquet, J., Nader, J. S., Hirigoyen, U., Petithomme, T., Combredet, C., Tostivint, E. P., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2377830 · Cited by 10 · see citing works

Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives

Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 10 · see citing works

Mutational Landmarks in Anaplastic Thyroid Cancer: A Perspective of a New Treatment Strategy

Pakkianathan, J., Yamauchi, C. R., Barseghyan, L., Cruz, J., Simental, A., & Khan, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092898 · Cited by 10 · see citing works

SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence

Tsanov, K. M., Barriga, F. M., Ho, Y.-J., Alonso‐Curbelo, D., Livshits, G., Tian, S., Koche, R. P., Baslan, T., Simon, J. M., Wuest, A. N., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01047-5 · Cited by 10 · see citing works

Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer

Yonesaka, K., Kurosaki, T., Tanizaki, J., Kawakami, H., Tanaka, K., Maenishi, O., Takamura, S., Sakai, K., Chiba, Y., Teramura, T., et al. (2025) · Cells · doi:10.3390/cells14060447 · Cited by 9 · see citing works

Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice

Tian, Y., Zhou, J., Qiao, J., Liu, Z., Gu, L., Zhang, B., Lu, Y., Xing, R., & Deng, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1038380 · Cited by 9 · see citing works

IFNε, IFNω and IFNλ: interferons defending the mucosa

Chuah, J. J. M., & Campbell, N. K. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102456 · Cited by 9 · see citing works

Striking the right balance with type I interferon signalling in cancer

Chadwick, T. B., So, J., Hertzog, P. J., Haynes, N. M., & Parker, B. S. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00915-1 · Cited by 9 · see citing works

FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma

Shboul, S. A., Boyle, S., Singh, A., Saleh, T., Alrjoub, M., Karsaneh, O. A. A., Mryyian, A., Dawoud, R., Gul, S., Baker, S. A., et al. (2023) · Brain Tumor Pathology · doi:10.1007/s10014-023-00473-6 · Cited by 8 · see citing works

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling

Chen, D., Cao, Y., Tang, H., Zang, L., Yao, N., Zhu, Y., Jiang, Y., Zhai, S., Liu, Y., Shi, M., et al. (2023) · Theranostics · doi:10.7150/thno.84978 · Cited by 7 · see citing works

CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma

Torricelli, F., Donati, B., Manicardi, V., Gugnoni, M., Reggiani, F., Manzotti, G., Chiaro, P. D., Ascione, C., Piana, S., Valli, R., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03522-4 · Cited by 7 · see citing works

Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma

Umbaugh, C. S., Groth, M., Erkut, C., Lee, K.-S., Marinho, J., Linder, S., Iser, F., Kapp, J. N., Schroeter, P., Dolaner, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2796 · Cited by 6 · see citing works

A disease model resource reveals core principles of tissue-specific cancer evolution

Mueller, S., Krätzig, N. D. A., Tschurtschenthaler, M., Silva, M. G., Thordsen, C., Trozzo, R., Simon, P., Saab, F., Kaltenbacher, T., Żukowska, M., et al. (2026) · Nature · doi:10.1038/s41586-026-10187-2 · Cited by 9 · see citing works

Exploring racial disparities in bladder urothelial cancer: insights into survival and genetic variations

Abubakar, S. D., Bello, Z. M., Gusau, S. S., & Kabir, I. M. (2024) · African Journal of Urology · doi:10.1186/s12301-024-00430-5 · Cited by 6 · see citing works

Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti–PD-1 in Murine Non–Small Cell Lung Cancer

Du, Y., Salehi‐Rad, R., Zhang, T.-H., Crosson, W. P., Abascal, J. W., Chen, D., Shi, Y., Jiang, H. F., Tseng, Y.-W., Ma, X., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1075 · Cited by 6 · see citing works

Single-cell analysis of signalling and transcriptional responses to type I interferons

Rigby, R. E., Rue-Albrecht, K., Fedorov, A., Sims, D., & Rehwinkel, J. (2026) · EMBO Reports · doi:10.1038/s44319-026-00750-3 · Cited by 7 · see citing works

Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome

Li, S., Li, W., Liu, B., Krysan, K., & Dubinett, S. M. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0564 · Cited by 7 · see citing works

Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response

Shahrouzi, P., Azimzade, Y., Brankiewicz, W., Bhatia, S., Kunke, D., Richard, D. J., Tekpli, X., Kristensen, V. N., & Duijf, P. H. G. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01924-4 · Cited by 6 · see citing works

The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes

Cheng, P., Singh, K., Reeves, R. H., & Davoli, T. (2025) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111723-103557 · Cited by 5 · see citing works

Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation

Rossi, T., Valgiusti, M., Puccetti, M., Miserocchi, G., Zanoni, M., Angeli, D., Arienti, C., Pace, I., Bassi, C., Vannini, I., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07530-2 · Cited by 5 · see citing works

VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING

Bertlin, J. A. C., Pauzaite, T., Liang, Q., Wit, N., Williamson, J. C., Sia, J. J., Matheson, N. J., Ortmann, B. M., Mitchell, T. J., Speak, A. O., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70517-w · Cited by 4 · see citing works

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms

Li, H., Luo, N., Fan, C., Han, T., Wei, X., Zhang, X., Dai, L., Ye, L., Chen, D., Cai, L., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14266-x · Cited by 4 · see citing works

Engineering megabase-sized genomic deletions with MACHETE (Molecular Alteration of Chromosomes with Engineered Tandem Elements)

Barriga, F. M., & Lowe, S. W. (2024) · Nature Protocols · doi:10.1038/s41596-024-00953-9 · Cited by 4 · see citing works

Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

Triboulet, R., Sadykov, K., Harvey, D. M., Wilson, D. M., Steinbaugh, M. J., Mayo, C. B., Hawley, D., Madanjian, A., Fyfe, C., Bracken, C., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0176 · Cited by 4 · see citing works

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility

Shah, P. A., Wiman, K. G., Cichowski, K. M., & Rodon, J. A. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-473616 · Cited by 4 · see citing works

Evolutionary fingerprints of EMT in pancreatic cancersPreprint

Perelli, L., Zhang, L., Mangiameli, S. M., Russell, A. J. C., Giannese, F., Peng, F., Carbone, F., Le, C. N., Khan, H., Citron, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.18.558231 · Cited by 4 · see citing works

To EMT or Not to EMT: Ablation of Mesenchymal Tumor Cell Lineages Reveals the Essential Role of EMT in Pancreatic Cancer Initiation and Evolution

Peura, J., Johnson, C., & Pitarresi, J. R. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1443 · Cited by 3 · see citing works

Prognostic model identification of ribosome biogenesis-related genes in pancreatic cancer based on multiple machine learning analyses

Sun, Y., Li, Y., Zhang, A., Hu, T., & Li, M. (2025) · Discover Oncology · doi:10.1007/s12672-025-02733-7 · Cited by 3 · see citing works

Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma

Parassiadis, C., & Johnsen, S. A. (2026) · Gastroenterology report · doi:10.1093/gastro/goag028 · Cited by 3 · see citing works

How CRISPR Is Revolutionizing the Generation of New Models for Cancer ResearchPreprint

Rivera, F. J. S., & Dow, L. E. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041384 · Cited by 4 · see citing works

Metastatic site influences driver gene function in pancreatic cancerPreprint

Tsanov, K. M., Barriga, F. M., Ho, Y.-J., Alonso‐Curbelo, D., Livshits, G., Koche, R. P., Baslan, T., Simon, J. M., Tian, S., Wuest, A. N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.17.585402 · Cited by 3 · see citing works

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumabPreprint

Park, R. J.-H., Parikh, M., Pappas, L., Sade-Feldman, M., Kulkarni, A. S., Bi, L., LaSalle, T. J., Galway, A., Kuhlman, C., Blaszkowsky, L. S., et al. (2024) · medRxiv · doi:10.1101/2024.10.08.24315092 · Cited by 3 · see citing works

Zinc availability in the tumor microenvironment dictates anti-PD1 response in CDKN2A Low tumors via increased macrophage phagocytosisPreprint

Buj, R., Cole, A. R., Danielson, J., Xu, J. P., Hurd, D. E., Kishore, A., Kedziora, K. M., Chen, J., Yang, B., Barras, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.08.637227 · Cited by 4 · see citing works

Genomic Landscape and Clinical Implications of MTAP Loss in Advanced Gastrointestinal Malignancies

Min-Ho, L., & Jin-Woo, C. (2024) · Archive of International Journal of Cancer and Allied Science · doi:10.51847/1wge2vwbfg · Cited by 2 · see citing works

Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors

Seguchi, K., Fujisawa, T., Ikeda, S., Oyama, Y., Nonomura, N., Morizane, C., Iwata, H., Okano, S., Watari, H., Namikawa, K., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-4936 · Cited by 2 · see citing works

LncRNA ZFHX4-AS1 as a novel biomarker in adrenocortical carcinoma

Chen, G., Li, S., Lü, J., Liang, A., Gao, P., Ou, F., Wang, Y., Li, Y., & Pan, B. (2024) · Translational Andrology and Urology · doi:10.21037/tau-23-649 · Cited by 2 · see citing works

Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of oesophageal cancerPreprint

Ganguli, P., Basanta, C. D. L. A. C., Acha‐Sagredo, A., Mišetić, H., Armero, M., Mendez, A., Zahra, A., Devonshire, G., Kelly, G. P., Freeman, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.24.576991 · Cited by 2 · see citing works

Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion–Defined Rhabdomyosarcoma

Bergsma, P., Porazinski, S. R., Istadi, A., Fajardo, D. C., Mahmood, Y., Lombardi, S., Schuhmacher, D., Barraclough-Franks, H., Strbenac, D., Dennis, C. V., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0704 · Cited by 1 · see citing works

Development and Validation of a Centrosome Amplification-Related Prognostic Model in Pancreatic Cancer: Multi-Omics Guided Risk Stratification and Tumor Microenvironment

Yuan, S., Hu, T., Yan, L., & Li, M. (2025) · Cancers · doi:10.3390/cancers17182983 · Cited by 1 · see citing works

Somatic copy number variation as a prognostic marker for recurrence in never‐smokers with early‐stage lung adenocarcinoma

Vanstraelen, S., Reiner, A., Tan, K. L., Mastrogiacomo, B., Dunne, E. G., Fick, C. N., Dycoco, J., Abass, A., Bott, M. J., Sánchez-Vega, F., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70373 · Cited by 1 · see citing works

Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities

Lisitsa, D. A., Shindyapin, V. V., Nurislamov, A. R., Demidov, O. N., & Bogdanova, D. A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1741704 · Cited by 1 · see citing works

Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets

Murthy, D., Seyhan, A. A., den Hollander, P., Lu, S., Kuburich, N. A., Gould, C., Karam, A., Sun, K., Schupp, P. G., Safran, H., et al. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101476 · Cited by 2 · see citing works

Type I and III interferons in asthma and respiratory infections: New insights for potential treatments

Jafari, Z., Nazhdi, Z. A., EmamAlizadeh, M., & Athari, S. S. (2026) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2026.106960 · Cited by 1 · see citing works

Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms

Pavlick, D. C., Rengarajan, S., Lee, J., Jin, D. X., Frampton, G. M., Fendler, B. J., Savol, A., Gjoerup, O. V., Tukachinsky, H., Huang, R. S. P., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-26-00037 · Cited by 1 · see citing works

Investigating the Consequences of Aneuploidy in Cancer and Normal Tissue

Modi, J. N., & Taylor, A. M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-22637-2_15 · Cited by 1 · see citing works

Primary mismatch repair deficient glioma, IDH-wildtype and H3-wildtype: A giant cell tumor with potential for long-term survival occurring at all ages

Suwala, A. K., Friedel, D., Hinz, F. E., Mahlknecht, P., Schinkewitsch, S., Rieder, M., Fernandez, N. R., Stengs, L. K., Chang, Y., Ringel, A., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag132 · Cited by 1 · see citing works

MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis

Arter, Z., Shim, J. S. G., Park, C., Waliany, S., Lim, S. M., & Soo, R. A. (2026) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2026.103204 · Cited by 1 · see citing works

SelectRepair Knockout: Efficient PTC-Free Gene Knockout Through Selectable Homology-Directed DNA Repair

Cortázar, M. A., & Jagannathan, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4176-7_23 · Cited by 1 · see citing works

Reannotation of cancer mutations based on expressed RNA transcripts reveals functional non-coding mutations in melanoma

Pepe, D., Janssens, X., Timcheva, K., Marrón-Liñares, G. M., Verbelen, B., Konstantakos, V., Groote, D. D., Bie, J. D., Verhasselt, A., Dewaele, B., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.04.005 · Cited by 1 · see citing works

Identification and liquid-liquid phase separation-Related Genes Prognosis Model in pancreatic cancer by comprehensive analysisPreprint

Sun, Y., Zhang, A., Li, Y., Hu, T., & Li, M. (2024) · Research Square · doi:10.21203/rs.3.rs-5655084/v1 · Cited by 1 · see citing works

Type I interferon signaling instills divergent metastatic phenotypes and immunotherapy responsesPreprint

Breuer, C. B., Labrado, M., Rodriguez, G. E., García, K. C., & Reticker-Flynn, N. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.18.677123 · Cited by 2 · see citing works

Disabling a key viral innate immunity antagonist converts measles vaccine into RIG-I–driven cancer immunotherapyPreprint

Barinov, A., Vera-Peralta, H., Nader, J. S., Najburg, V., Combredet, C., Arbabian, A., Gracias, S., Frantz, P. N., Vibert, R., Simard, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680227 · Cited by 1 · see citing works

Studying large genomic deletions with MACHETE

Barriga, F. M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00561-x

Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor SuppressionPreprint

Barriga, F. M., Tsanov, K. M., Ho, Y.-J., Sohail, N., Zhang, A. X. W., Baslan, T., Wuest, A. N., Priore, I. S. D., Meškauskaitė, B., Livshits, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.22.504793 · Cited by 1 · see citing works

MACHETE Reveals Large 9p21.3 Deletions Mediate Immune Evasion and Metastasis

(2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2022-203

Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction

Zhao, X., Liu, B., William, W. N., Tsanov, K. M., Ho, Y.-J., Barriga, F. M., Lim, R. J., Trifas, M., Khandekar, A., Du, Y., et al. (2024) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2024.12.020 · Cited by 17 · see citing works

Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance

Ye, Z., Dong, H., Li, Y., Ma, T., Huang, H., Leong, H. S., Eckel‐Passow, J. E., Kocher, J., Liang, H., & Wang, L. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3008 · Cited by 60 · see citing works

Prevailing homozygous deletion of interferon and defensin genes in human cancersPreprint

Ye, Z., Dong, H., Li, Y., Huang, H., Liang, H., Kocher, J., & Wang, L. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/101741